Congress·Bill·H.R. 9635

To amend the Federal Food, Drug, and Cosmetic Act to establish special rules to provide for continued review of human drug and device submissions during a lapse of appropriations, and for other purposes.

2 days ago·View on Congress.gov

Legislative Progress

House

Senate

President

Law

Key Points

Full text not yet published

Congress hasn’t released the official text of this legislation yet. Once it’s published, this page will be updated with key points, impact assessments, and more.

Impact Analysis

Govbase has not yet run an impact analysis on this legislation.

No votes, news coverage, or related bills recorded for this bill yet.

Source Information

Document Type

Congressional Bill

Bill NumberHR 9635

Congress119th Congress

Data Sources

Congress.gov

Official legislative information

Sponsor

Analysis generated by AI. Always verify with official sources.